Mycotoxin Occurrence, Exposure and Health Implications in Infants and Young Children in Sub-Saharan Africa: A Review

Cynthia Adaku Chilaka1, Angela Mally1

  • 1Institute of Pharmacology and Toxicology, Julius Maximilian University of Würzburg, Versbacher Straβe 9, 97078 Würzburg, Germany.

Insights

Infants and young children in sub-Saharan Africa face significant health risks from mycotoxins in food and breast milk. Early exposure, exacerbated by poor practices and lack of regulation, necessitates urgent protective measures.

Area of Science:

  • Environmental Health
  • Food Safety
  • Pediatrics

Background:

  • Infants and young children (IYC) in sub-Saharan Africa (SSA) are highly vulnerable to environmental hazards.
  • Mycotoxins, toxic fungal metabolites, pose a significant health risk to IYC in SSA.
  • Factors like socioeconomic status, poor agricultural practices, and limited awareness worsen mycotoxin exposure in SSA.

Purpose of the Study:

  • To provide an overview of mycotoxin occurrence in foods for IYC in SSA.
  • To discuss evidence of mycotoxin exposure in IYC in SSA.
  • To examine the health implications of mycotoxin exposure for IYC in SSA.

Main Methods:

  • Review of studies on mycotoxin occurrence in IYC foods in SSA.
  • Analysis of consumption data and food occurrence data.
  • Inclusion of biomonitoring approaches for exposure assessment.

Main Results:

  • Mycotoxins are present in breast milk and weaning foods consumed by IYC in SSA.
  • Early life exposure occurs via transplacental transfer and breastfeeding.
  • Health risks are elevated due to lack of regulatory limits and enforcement.

Conclusions:

  • IYC in SSA are significantly exposed to mycotoxins through diet.
  • Maternal exposure leads to infant exposure, posing adverse health effects.
  • Addressing agricultural, storage, and regulatory issues is crucial for IYC protection.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.8K
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
292
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
2.9K
Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
700
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
122